Back to search

Article

Implementing Radical Cure Diagnostics for Malaria: User Perspectives on G6PD Testing in Bangladesh

2020-11-09

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> The radical cure of <italic>Plasmodium vivax</italic> requires treatment with an 8-aminoquinoline drug, such as primaquine and tafenoquine, to clear the liver of parasites which can reactivate to cause relapsing infections. Safe treatment regimens require prior screening of patients for glucose-6-phosphate dehydrogenase (G6PD) deficiency to avoid potential life-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5a38fccf-1444-5794-ad91-dc578df17869
DOI
10.21203/rs.3.rs-101549/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Implementing Radical Cure Diagnostics for Malaria: User Perspectives on G6PD Testing in BangladeshDOI 10.21203/rs.3.rs-101549/v1
Assessment of Glucose-6 phosphate dehydrogenase deficiency in malaria suspected patients attending at Shele and Lante Health Center, Southern EthiopiaSemantic proximity
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of<i>Plasmodium vivax</i>malaria in Indonesia and Papua New Guinea: The SCOPE implementation study protocolSemantic proximity
Quantitative G6PD point-of-care test can be used reliably on cord blood to identify male and female newborns at increased risk of neonatal hyperbilirubinaemia: a mixed method studySemantic proximity
Acceptance and Perceived Value of Non-Invasive Malaria Diagnostic Tests in Malaria-Endemic CountriesSemantic proximity
Experiences of healthcare personnel on the efficacy of artemisinin-based combination therapies and malaria diagnosis in hospitals in UgandaSemantic proximity
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in MauritaniaSemantic proximity
Secondary Analysis on Malaria RDTs in WHO Product Testing from Round 5 to 8 on False Negative Results in Testing SampleSemantic proximity
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.Semantic proximity
Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.Semantic proximity
Safety Monitoring Experience of Single-low Dose Primaquine Co-administered With Artemether-lumefantrine Among Providers and Patients in Routine Healthcare Practice: a Qualitative Study in Eastern TanzaniaSemantic proximity
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.Semantic proximity
Low practical knowledge but high willingness to use of rapid diagnostic tests for malaria by healthcare workers in Republic of CongoSemantic proximity
Select a neighboring publication to make it the new centre.